GLP-1 medications like Ozempic and Wegovy have become the most talked-about drugs in the world. Originally developed for type 2 diabetes, they suppress appetite so effectively that users report losing interest in food entirely — not just eating less, but losing cravings for alcohol, ultra-processed food and even compulsive behaviors. Food companies are scrambling to reformulate products for GLP-1 users who want maximum protein and fiber in minimal calories. Restaurants are seeing smaller portion sizes ordered. Some nutritionists celebrate the shift. Others warn that Ozempic is treating symptoms not causes and creating a generation dependent on injections to control eating. Is Ozempic genuinely changing how the world eats?
